TOPGUN

The TOPGUN program is a platform for peptidomimetic theranostic development and GMP production, presenting a two-fold opportunity:

1. The development of new peptide-based molecules that can be used in cancer diagnostics. The aim is to develop a platform for the systematic downsizing of nanobodies into peptides that can maintain or improve the functional activity and, where possible, eliminate or reduce their limitations.
2. A centralised GMP production facility for radiopharmaceuticals, the Brussels Imaging Pharmacy (BIP). This opportunity also includes a cyclotron and a quality control lab. BIP is also a center of expertise in clinical trials and regulatory processes.